U.S. federal trademark · Serial No. 97695978
Our technology is an RNA editing platform that delivers therapies for rare and chronic diseases. We deliver edit-to-cure therapeutics for undruggable target conditions by using RNA-editing to address the root cause of disease progression
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.